| MCISX | VFSNX | MCISX / VFSNX | |
| Total Expense Ratio | 2.10 | 0.08 | 2,625% |
| Annual Report Gross Expense Ratio | 3.49 | 0.08 | 4,363% |
| Fund Existence | 19 years | 17 years | - |
| Gain YTD | 11.645 | 9.759 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.71B | 14.3B | 33% |
| Annual Yield % from dividends | 0.89 | 2.99 | 30% |
| Returns for 1 year | 23.76 | 21.87 | 109% |
| Returns for 3 years | 60.40 | 45.57 | 133% |
| Returns for 5 years | 24.60 | 21.30 | 115% |
| Returns for 10 years | 112.83 | 89.95 | 125% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NQQQX | 55.06 | 1.64 | +3.07% |
| Shelton Nasdaq-100 Index Institutional | |||
| CTSOX | 64.46 | 1.12 | +1.77% |
| Calamos Timpani Small Cap Growth R6 | |||
| SVALX | 7.10 | N/A | N/A |
| Federated Hermes Strategic Value Div R6 | |||
| GMSRX | 14.80 | N/A | N/A |
| Nationwide Small Cap Index R | |||
| LYFCX | 16.07 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||